30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Avagliano Mark

Insider profile

Performance

Overall performance
2.4

Performance over holding periods
2.4
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 74% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Avagliano Mark's trades of G1 Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-07-08 2024-07-05 S Sale
48,721 -35.8%
421.03
US$4,099,930
48,721 -35.8% 421.03 US$4,099,930
2024-05-15 2024-05-13 S Sale
90,277 -38.3%
67.95
US$241,685
90,277 -38.3% 67.95 US$241,685
2024-01-08 2024-01-04 S Sale
23,502 +36.4%
22.99
US$2,458,245
23,502 +36.4% 22.99 US$2,458,245
2024-01-08 2024-01-03 S Sale
2,602 -2.1%
3.12
US$8,115
2,602 -2.1% 3.12 US$8,115
2024-01-08 2024-01-03 S Sale
758 -0.6%
3.12
US$2,364
758 -0.6% 3.12 US$2,364
2022-01-05 2022-01-05 S Sale
1,445 -6.3%
10.61
US$15,334
1,445 -6.3% 10.61 US$15,334